rifasutenizol   Click here for help

GtoPdb Ligand ID: 12959

Synonyms: TNP-2198
Compound class: Synthetic organic
Comment: Rifasutenizol (formerly TNP-2198) is a rifamycin-nitroimidazole conjugate antibacterial compound [1]. Note that there is some ambiguity in the literature and online chemistry resources as to the precise stereochemistry of this ligand. We have drawn the structure as depicted in its INN record.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 17
Hydrogen bond donors 5
Rotatable bonds 7
Topological polar surface area 264.29
Molecular weight 944.04
XLogP 3.02
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1/C=C/C=C(/C)\C(=O)NC2=C3C(=NC4(CCN(CC4)CCN5C(=NC=C5[N+](=O)[O-])C)N3)C6=C7C(=C(C)C(=C6C2=O)O)O[C@@](C)(C7=O)O/C=C/[C@@H]([C@@H](C)[C@H]([C@H](C)[C@@H]([C@H](C)[C@H]1O)O)OC(=O)C)OC
Isomeric SMILES O=C1C=2NC(/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](\C=C\O[C@]3(OC=4C(=C(C1=C(C=5C2NC6(N5)CCN(CCN7C([N+]([O-])=O)=CN=C7C)CC6)C4C3=O)O)C)C)OC)C)OC(C)=O)C)O)C)O)C)/C)=O
InChI InChI=1S/C48H61N7O13/c1-23-12-11-13-24(2)46(62)50-38-37-36(51-48(52-37)15-17-53(18-16-48)19-20-54-29(7)49-22-32(54)55(63)64)33-34(42(38)60)41(59)28(6)44-35(33)45(61)47(9,68-44)66-21-14-31(65-10)25(3)43(67-30(8)56)27(5)40(58)26(4)39(23)57/h11-14,21-23,25-27,31,39-40,43,52,57-59H,15-20H2,1-10H3,(H,50,62)/b12-11+,21-14+,24-13-/t23-,25+,26+,27+,31-,39-,40+,43+,47-/m0/s1
InChI Key GVNMWVKTEANXFY-AIGATTFSSA-N
No information available.
Summary of Clinical Use Click here for help
Rifasutenizol is being evaluated as a treatment for Helicobacter Pylori infections.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05857163 Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection Phase 3 Interventional TenNor Therapeutics Inc.
NCT06076681 A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules Phase 1/Phase 2 Interventional TenNor Therapeutics Inc.
NCT06076694 Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants Phase 2 Interventional TenNor Therapeutics Inc.